Teclistamab salvage therapy for multiple myeloma relapse after allogeneic hemopoietic stem cell transplant: A case report
Am J Hematol
.
2024 Jan;99(1):E29-E31.
doi: 10.1002/ajh.27159.
Epub 2023 Nov 30.
Authors
Francesco Zaja
1
2
,
Elisa Lucchini
2
,
Monica Poiani
2
,
Eugenio Sbisà
2
,
Sara Mohamed
2
,
Eleonora De Bellis
2
,
Manuela Caizzi
2
,
Clara Palmieri
3
,
Stefano Loiacono
3
,
Marilena Granzotto
4
,
Francesca Sirianni
4
,
Giovanni De Sabbata
2
Affiliations
1
Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università degli Studi di Trieste, Trieste, Italy.
2
UCO Ematologia, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.
3
SC Farmacia Ospedaliera e Territoriale, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.
4
Laboratorio Unico, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.
PMID:
38032813
DOI:
10.1002/ajh.27159
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Antineoplastic Agents* / therapeutic use
Hematopoietic Stem Cell Transplantation*
Humans
Multiple Myeloma* / drug therapy
Neoplasm Recurrence, Local
Salvage Therapy
Transplantation, Autologous
Substances
Antineoplastic Agents